Balyasny’s $78.78B Q4 2025 13F Shows a Pod Shop Still Spreading Risk Across 500 Positions
Balyasny Asset Management reported $78.78B in Q4 2025 13F AUM, but its top five U.S. long positions made up only 13.9% of the book — a clear sign of platform-level diversification.
Balyasny Asset Management’s Q4 2025 filing is a useful reminder that a giant hedge fund can look busy without looking concentrated. Balyasny reported $78.78B in 13F AUM for 2025Q4, yet its five largest disclosed U.S. long positions — QQQ, AMZN, NVDA, MSFT, and IWM — accounted for only 13.9% of the book. That is not the profile of a one-theme hedge fund. It is the profile of a platform still spreading risk aggressively across sectors, instruments, and trading teams.
TL;DR
- Balyasny reported $78.78B in Q4 2025 13F AUM with 500 disclosed positions.
- The top position, QQQ, was only 3.73% of the U.S. long book, and the top five totaled just 13.9%.
- The top 10 included broad market exposure plus mega-cap tech and financials: QQQ, AMZN, NVDA, MSFT, IWM, TSLA, SPY, XLF, META, and GOOGL.
- Public firm materials describe Balyasny as a multi-strategy platform spanning equity L/S, fixed income and macro, commodities, multi-asset arbitrage, and quantitative investing. The 13F only captures the U.S. long sleeve, but the filing still reflects that diversified operating model.
Balyasny’s largest disclosed Q4 2025 positions were broad and balanced
Why this filing matters
The headline is not that Balyasny owns a lot of big-cap tech. Plenty of managers do. The real signal is how little concentration sits on top of a very large asset base. A $78.78B filer with a 3.73% top position and a 13.9% top-five weight is telling you that portfolio construction matters more here than stock-level storytelling.
That lines up with what Balyasny says publicly about the business. The firm’s strategy materials emphasize cross-strategy collaboration across equities, macro, credit, commodities, arbitrage, and quant. Its Form ADV also describes a broad alternative platform rather than a narrow long-only franchise. In plain English: this is a hedge fund machine built to distribute risk, not to advertise one flagship bet.
What did Balyasny buy in Q4 2025?
The disclosed top book reads like a fast-moving risk basket rather than a classic value manager’s permanent favorites. Balyasny’s biggest reported positions included growth leaders such as NVDA, MSFT, AMZN, META, and GOOGL, but it also leaned into ETFs like QQQ, IWM, SPY, and XLF. That mix matters. ETFs can be used to express factor, sector, or liquidity views quickly, while the single-name positions provide more targeted alpha exposure.
Even further down the top 20, the mix stays eclectic: AAPL, SMH, AVGO, TSM, EA, NSC, GDX, KVUE, and KRE all appear. That is exactly what you would expect from a multi-pod platform whose job is to keep many independent risk books running at once.
Filing snapshot: low concentration at massive scale
| Metric | Q4 2025 | Read-through |
|---|---|---|
| Reported 13F AUM | $78.78B | Very large disclosed U.S. long book |
| Disclosed positions | 500 | Wide position spread even after 13F filtering |
| Top holding | QQQ at 3.73% | No single position dominates risk |
| Top five concentration | 13.9% | Diversification is the core message |
| Top 10 concentration | 22.9% | Still unusually low for a manager this large |
For comparison, many concentrated equity shops can put 25% to 40% of a portfolio into their top five names. Balyasny is nowhere near that profile. The filing looks more like a balance sheet for a trading platform than a persuasion document for a handful of conviction longs.
Balyasny’s AUM scaled sharply into late 2025 while concentration stayed low
AUM history says the platform scaled, but the exposure stayed diffuse
Balyasny’s AUM history shows rapid growth into late 2025. The firm moved from $57.25B in 2024Q1 to $78.78B in 2025Q4. The most dramatic jump came in 2025Q3, when the reported book reached $78.91B, up 18.8% quarter over quarter. Q4 then held essentially flat at -0.2% sequentially, but the disclosed holdings count still expanded from 2,843 to 3,338 in the historical series.
That combination is important. Flat AUM with more line items usually means the platform kept recycling capital across a broader opportunity set rather than doubling down on a few crowded winners. It fits a pod-shop operating logic: distribute risk, keep capital mobile, and let different teams express views through a mix of liquid single names and macro-friendly ETFs.
How should investors read a pod-shop 13F?
The safest interpretation is also the most useful one: a Balyasny 13F is a window into risk distribution, not the full P&L engine. The public filing excludes short positions, derivatives, credit books, macro trades, and much of the rest of the multi-strategy complex. But even within that limited view, the Q4 2025 report says a lot.
It says the platform still wanted exposure to U.S. equity beta through QQQ, SPY, and IWM. It says the firm stayed engaged with AI and mega-cap growth through NVDA, MSFT, META, and GOOGL. And it says sector and tactical overlays still mattered, with meaningful size in XLF and semiconductor exposure via SMH.
The takeaway is that Balyasny’s Q4 filing does support the pod-shop narrative, but not in the simplistic way people usually mean it. The real tell is not frenetic turnover. It is the ability to run a huge book while keeping single-name concentration modest.
Analyst’s take
If you were looking for one dramatic Balyasny stock call in Q4 2025, this filing is not built for that. If you wanted to know whether the platform still behaves like a diversified, fast-reacting multi-strategy machine, the answer is yes. The top of the book spans index exposure, mega-cap tech, financials, and cyclical names, and the concentration statistics stay low despite the size of the franchise.
That is why the best way to read Balyasny’s latest 13F is not as a shopping list. It is as confirmation that the firm entered year-end with breadth, liquidity, and optionality — all traits that matter when a hedge fund platform is trying to preserve capital efficiency across many internal books at once.
Frequently asked questions
What did Balyasny buy in Q4 2025?
Its largest disclosed U.S. long positions included QQQ, AMZN, NVDA, MSFT, IWM, TSLA, SPY, XLF, META, and GOOGL.
Is Balyasny concentrated in one stock?
No. The largest disclosed position was QQQ at 3.73%, and the top five holdings together were only 13.9% of the filing.
Why does Balyasny own so many ETFs and mega-cap names?
Because the filing looks like a liquidity-aware multi-strategy platform book. ETFs can help express broad market or sector views quickly, while mega-cap single names add targeted exposure.
Does the 13F show Balyasny’s whole portfolio?
No. A 13F only shows long U.S. equity-style holdings. It does not reveal short books, most derivatives, credit, macro, or commodities exposures that are central to many multi-strategy hedge funds.
Related Research
Explore all researchJanus Henderson kept Nvidia and Microsoft on top in Q4 2025, but the more interesting signal was underneath: new exposure to Intuitive Surgical, Protagonist Therapeutics and other growth-healthcare names. The next filing will show whether that rotation keeps building.
Apr 17, 2026
Principal’s Q4 2025 filing looked slightly weaker on headline AUM, but the internal rotation was more revealing: Brookfield became a top-ten position, Netflix surged, and the fund cut back in parts of real estate. The next filing will show whether that shift keeps going.
Apr 17, 2026
Dodge & Cox’s Q4 2025 filing barely moved on headline AUM, but the underlying changes were more interesting: fresh positions in Brookfield, TransUnion and PDD inside a still-diversified value book. The next filing will show whether those adds were conviction moves or just incremental reshuffling.
Apr 17, 2026
AQR’s Q4 2025 filing kept expanding, with AUM rising to $190.63B, 69 new names, and a dramatic Bristol Myers build inside an already broad book. The next filing will show whether the quant giant keeps pressing this expansion or starts normalizing the roster again.
Apr 17, 2026
American Century’s Q4 2025 filing kept Nvidia and Microsoft on top, but the more revealing changes were the big Netflix increase, fresh utility and industrial additions, and a continued AI-heavy core. The next filing will show whether those side bets keep scaling.
Apr 17, 2026